A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations
Human Molecular Genetics · 19.06.2023 · 32 (13) · 2177-2191
DOI: 10.1093/hmg/ddad054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 03.04.2023. Verfasst von Rebecca Meyer-Schuman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Alanine-tRNA Ligase, Peripheral Nervous System Diseases, Amino Acyl-tRNA Synthetases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, Michigan Pre-doctoral Training in Genetics Program.
Abstract (Originalsprache)
Aminoacyl-tRNA synthetases (ARSs) are essential enzymes that ligate tRNA molecules to cognate amino acids. Heterozygosity for missense variants or small in-frame deletions in six ARS genes causes dominant axonal peripheral neuropathy. These pathogenic variants reduce enzyme activity without significantly decreasing protein levels and reside in genes encoding homo-dimeric enzymes. These observations raise the possibility that neuropathy-associated ARS variants exert a dominant-negative effect, reducing overall ARS activity below a threshold required for peripheral nerve function. To test such variants for dominant-negative properties, we developed a humanized yeast assay to co-express pathogenic human alanyl-tRNA synthetase (AARS1) mutations with wild-type human AARS1. We show that multiple loss-of-function AARS1 mutations impair yeast growth through an interaction with wild-type AARS1, but that reducing this interaction rescues yeast growth. This suggests that neuropathy-associated AARS1 variants exert a dominant-negative effect, which supports a common, loss-of-function mechanism for ARS-mediated dominant peripheral neuropathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
- Department of Chemistry, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
- Northcott Neuroscience Laboratory, ANZAC Research Institute, Sydney, NSW 2139, Australia.
- Sydney Medical School, University of Sydney, Sydney, NSW 2050, Australia.
- Molecular Medicine Laboratory, Concord General Repatriation Hospital, Sydney, NSW 2139, Australia.
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
- Michigan Pre-doctoral Training in Genetics Program
- National Institutes of Health
Zitieren
APA
Meyer-Schuman, R., Marte, S., Smith, T. J., Feely, S. M. E., Kennerson, M., Nicholson, G., Shy, M. E., Koutmou, K. S., & Antonellis, A. (2023). A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations. Human Molecular Genetics, 32(13), 2177-2191. https://doi.org/10.1093/hmg/ddad054
Vancouver
Meyer-Schuman R, Marte S, Smith TJ, Feely SME, Kennerson M, Nicholson G, et al. A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations. Human Molecular Genetics. 2023;32(13):2177-2191. doi:10.1093/hmg/ddad054
BibTeX
@article{MeyerSchuman2023,
author = {Meyer-Schuman, Rebecca and Marte, Sheila and Smith, Tyler J and Feely, Shawna M E and Kennerson, Marina and Nicholson, Garth and Shy, Mike E and Koutmou, Kristin S and Antonellis, Anthony},
title = {A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations},
journal = {Human Molecular Genetics},
year = {2023},
volume = {32},
number = {13},
pages = {2177--2191},
doi = {10.1093/hmg/ddad054}
}
EUVIMED